EGFR
Boehringer's Jardiance now gets CDSCO nod for chronic kidney disease
The Central Drugs Standard Control Organisation of India has approved Jardiance, a 10mg dosage form of empagliflozin, for the treatment of chronic kidney disease (CKD). This approval allows nephrologists and cardiologists to use Jardiance for eligible CKD patients, reducing hospitalizations and addressing unmet medical needs.
Sun Pharma inks pact with Bayer to sell drug for chronic kidney disease
Sun Pharma has partnered up with Bayer to market Finerenone, a drug for chronic kidney disease, in India. Bayer grants non-exclusive rights to Sun Pharma to distribute Finerenone under the brand name Lyvelsa. Sun Pharma CEO emphasizes commitment to providing innovative medicines to Indian patients.
Cancer therapy firm Bicara raises $165 million
Bicara, founded in 2020 and based in Cambridge, Massachusetts, is a clinical-stage biotechnology company currently developing dual-action biologics to produce a potent and durable immune response.
Tobacco leaves have a compound to fight several types of cancer: Study
Researchers from various countries, including an alumnus of Allahabad University, have discovered a compound derived from tobacco leaves that shows promise in fighting several types of cancer. The compound, named "4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline," was found to have no noticeable side effects and targets the epidermal growth factor receptor (EGFR) protein in tumor cells.
Miracle pill can keep lung cancer at bay: Report
The treatment developed by the pharmaceutical group AstraZeneca is called osimertinib and is marketed under the name Tagrisso.
How to check kidney's health? Here are two simple tests
You may be losing kidney functions for many years without significant symptoms. People often get to know about their condition only when their kidneys have failed and it's too late for preventive treatment. In this situation, they usually need dialysis or a kidney transplant. That's why knowing your kidney numbers is important.
- Go To Page 1
Kidneys disease: How to reduce Creatinine levels naturally?
In most cases, the kidneys' functioning is hindered because of high blood pressure or diabetes. Both these factors are the primary causes of kidney damage. To reduce creatinine levels, it is advised to keep blood pressure and sugar within normal limits so that no further damage happens.
How lung cancer arises in non-smokers revealed
Lung cancer is the leading cause of cancer-related deaths worldwide. Environmental risk factors, such as exposure to radon, air pollution, and asbestos, or having had previous lung diseases, may explain some lung cancers among never smokers, but scientists still don't know what causes the majority of these cancers.
New AI system may be able to identify lung cancer type
The AI tool was also able to determine whether abnormal versions of 6 genes linked to lung cancer were present in cells.
Indian-US team identifies genetic target for treating colorectal cancer
Also called colon, rectal or bowel cancer, CRC is the third most common cancer in men and the second in women worldwide.
Good cancer drug data helps AstraZeneca in Pfizer fight
Britain's second-biggest drugmaker has rejected a $106 billion approach from its US rival Pfizer, arguing that it has a bright future.
Biocon rolls out its first biologic drug for the treatment of psoriasis
Called ALZUMAb, it took 10 years in the making and "is recognition of innovation done by research and development wing of Biocon," said Kiran Mazumdar-Shaw.
Biocon seeking partners to develop, market psoriasis drug
Biotechnology major Biocon today said it is looking for partners to develop and market its novel biologic drug Itolizumab
Biocon to launch psoriasis drug novel biologic in July
The company had received marketing authorisation for Itolizumab from the Drugs Controller General of India (DCGI) in January, 2013.
Biocon launches stand alone cardiology division
Biotech major, Biocon, has decided to split its cardio-diabetes group by launching a stand alone cardiology division.
Load More
